WALL STREET ASSOCIATES - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 58 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$1,385,000
+76.7%
170,4000.0%0.47%
+50.3%
Q2 2016$784,000
+10.3%
170,4000.0%0.31%
+6.4%
Q1 2016$711,000
-46.1%
170,4000.0%0.30%
-20.5%
Q4 2015$1,319,000
-40.3%
170,4000.0%0.37%
-12.3%
Q3 2015$2,210,000
-24.2%
170,400
-11.4%
0.42%
+53.8%
Q2 2015$2,915,000192,4000.28%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$48,409,0001.87%
RA Capital Management 612,863$7,949,0001.14%
TIGER MANAGEMENT L.L.C. 650,915$8,442,0001.13%
Opaleye Management Inc. 175,200$2,272,0001.12%
Rock Springs Capital Management LP 489,000$6,342,0000.52%
WALL STREET ASSOCIATES 170,400$2,210,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 201,720$2,616,0000.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 418,903$5,433,0000.26%
SABBY MANAGEMENT, LLC 384,734$4,990,0000.21%
DAFNA Capital Management LLC 15,000$195,0000.19%
View complete list of NIVALIS THERAPEUTICS INC shareholders